Disaster Looms as Antibiotics Lose Their Efficacy

Share it with your friends Like

Thanks! Share it with your friends!

Close

By Admin

by Dr. Robert J. Rowen

Here is a telling report from the left wind New York Times actually accurately reporting a crisis we face with infectious diseases. For many reasons outlined, companies that develop antibiotics simply aren’t making it. The reasons are many. I’ll outline a few.

New drug development is extremely costly due to regulatory requirements. A new antibiotic course of therapy might cost $2000 compared to a few dollars per pill of older drugs.

Doctors are (at last) more reluctant to …read more

Source: Health Impact News

    

  • Rating:
  • Views:199 views
  • Categories: Health